Head of Discovery Medicine - Cardiovascular @ Responsible for the definition of the clinical plan and for the design and implementation of the early clinical studies and of exploratory clinical research required to inform both discovery and development; responsible for translational R&D activities across early development. Working closely with cardiovascular discovery to identify novel targets that address unmet medical needs. From 2015 to Present (less than a year) Executive Director, Cardiometabolic Disease Biology (Thrombosis and Chronic Kidney Disease) @ Cardiometabolic Drug Discovery From 2012 to 2015 (3 years) Senior Research Fellow / Group Director @ Thrombosis Research From 2003 to 2012 (9 years) Director @ Mechanistic Pharmacology; Alzheimer's drug discovery; Biomarker development; Target identification and validation; Clinical development From 1996 to 2001 (5 years)

Venia Docendi, Medical Physiology @ Universität Wien From 1991 to 1993 MD, Medicine @ University of Münster From 1980 to 1986 Dietmar Seiffert is skilled in: Drug Discovery, Pharmacology, Clinical Development, Pharmaceutical Industry, Drug Development, Biomarkers, Target Identification, Validation, Translational Research, Molecular Biology, Pharmacodynamics, Thrombosis, Pharmaceuticals, Biomarker Discovery, Vascular Biology